Skip to Content
Contact Form Map & Directions Videos

Author: Cal Warriner

Amylin Held Back Safety Data from FDA on Diabetes Drug

06/30/2012
Articles
BY

Documents recently posted to the FDA’s website say pharmaceutical company, Amylin, has not been completely forthcoming about its diabetes drug, Byetta, and related drug Bydureon, concerning their potential for cardiovascular complications. The active ingredient is the same in the two drugs which are both used to treat type 2 diabetes. However, Bydureon […]

Read More

Hear What Our Clients Have To Say

"Every question that I had was answered in mere minutes and the follow through that the staff, secretaries and attorneys had was superior. I have dealt with many, many firms that have all disappointed me and Searcy Denney was by far the most thorough - I highly recommend them!"
Posted By: Susan Baker